Authors:
PREVOSTBLONDEL A
ZIMMERMANN C
STEMMER C
KULMBURG P
ROSENTHAL FM
PIRCHER H
Citation: A. Prevostblondel et al., TUMOR-INFILTRATING LYMPHOCYTES EXHIBITING HIGH EX-VIVO CYTOLYTIC ACTIVITY FAIL TO PREVENT MURINE MELANOMA TUMOR-GROWTH IN-VIVO, The Journal of immunology (1950), 161(5), 1998, pp. 2187-2194
Authors:
KULMBURG P
VEELKEN H
SCHMOOR C
ROSENTHAL FM
MACKENSEN A
LINDEMANN A
MERTELSMANN R
Citation: P. Kulmburg et al., NTS INFLUENCE ON TRANSGENE EXPRESSION FROM MONOCISTRONIC AND BICISTRONIC PLASMID VECTORS AFTER LIPOFECTION IN A HUMAN FIBROBLAST CELL-LINE, Journal of molecular medicine, 75(3), 1997, pp. 223-229
Authors:
KULMBURG P
RADKE M
MEZES B
MERTELSMANN R
ROSENTHAL FM
Citation: P. Kulmburg et al., CLONING AND SEQUENCE-ANALYSIS OF THE IMMEDIATE PROMOTER REGION AND CDNA OF PORCINE GRANULOCYTE-COLONY-STIMULATING FACTOR, Gene, 197(1-2), 1997, pp. 361-365
Citation: Fm. Rosenthal et G. Kohler, COLLAGEN AS MATRIX FOR NEO-ORGAN FORMATION BY GENE-TRANSFECTED FIBROBLASTS, Anticancer research, 17(2A), 1997, pp. 1179-1186
Authors:
VEELKEN H
MACKENSEN A
LAHN M
KOHLER G
BECKER D
FRANKE B
BRENNSCHEIDT U
KULMBURG P
ROSENTHAL FM
KELLER H
HASSE J
SCHULTZESEEMANN W
FARTHMANN EH
MERTELSMANN R
LINDEMANN A
Citation: H. Veelken et al., A PHASE-I CLINICAL-STUDY OF AUTOLOGOUS TUMOR-CELLS PLUS INTERLEUKIN-2-GENE-TRANSFECTED ALLOGENEIC FIBROBLASTS AS A VACCINE IN PATIENTS WITHCANCER, International journal of cancer, 70(3), 1997, pp. 269-277
Authors:
LAHN M
KOHLER G
SCHMOOR C
DENGLER W
VEELKEN H
BREENSCHEIDT U
MACKENSEN A
KULMBURG P
HENTRICH I
JESUITER H
ROSENTHAL FM
FIEBIG HH
SOMMERKAMP H
FARTHMANN EH
HASSE J
MERTELSMANN R
LINDEMANN A
Citation: M. Lahn et al., PROCESSING OF TUMOR-TISSUES FOR VACCINATION WITH AUTOLOGOUS TUMOR-CELLS, European surgical research, 29(4), 1997, pp. 292-302
Authors:
ROSENTHAL FM
KULMBURG P
FRUH R
PFEIFER C
VEELKEN H
MACKENSEN A
KOHLER G
LINDEMANN A
MERTELSMANN R
Citation: Fm. Rosenthal et al., SYSTEMIC HEMATOLOGICAL EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR PRODUCED BY IRRADIATED GENE-TRANSFECTED FIBROBLASTS, Human gene therapy, 7(17), 1996, pp. 2147-2156
Authors:
VEELKEN H
RE D
KULMBURG P
ROSENTHAL FM
MACKENSEN A
MERTELSMANN R
LINDEMANN A
Citation: H. Veelken et al., SYSTEMATIC EVALUATION OF CHIMERIC MARKER GENES ON DICISTRONIC TRANSCRIPTION UNITS FOR REGULATED EXPRESSION OF TRANSGENES IN-VITRO AND IN-VIVO, Human gene therapy, 7(15), 1996, pp. 1827-1836
Authors:
HERBST B
KOHLER G
MACKENSEN A
VEELKEN H
KULMBURG P
ROSENTHAL FM
SCHAEFER HE
MERTELSMANN R
FISCH P
LINDEMANN A
Citation: B. Herbst et al., IN-VITRO DIFFERENTIATION OF CD34(-POSITIVE LANGERHANS CELL AND THE INTERDIGITATING DENDRITIC CELL-TYPE() HEMATOPOIETIC PROGENITOR CELLS TOWARD DISTINCT DENDRITIC CELL SUBSETS OF THE BIRBECK GRANULE AND MIIC), Blood, 88(7), 1996, pp. 2541-2548
Authors:
LINDEMANN A
KOHLER G
MACKENSEN A
VEELKEN H
ROSENTHAL FM
SCHAEFER HE
FISCH P
MERTELSMANN R
HERBST B
Citation: A. Lindemann et al., IN-VITRO DIFFERENTIATION OF CD34(-POSITIVE LANGERHANS CELL AND THE INTERDIGITATING DENDRITIC CELL-TYPE() HEMATOPOIETIC PROGENITOR CELLS TOWARDS DISTINCT DENDRITIC CELL SUBSETS OF THE MIIC), Blood, 88(10), 1996, pp. 601-601
Authors:
ROSENTHAL FM
FRUH R
KOHLER G
KULMBURG P
VEELKEN H
MACKENSEN A
LINDEMANN A
MERTELSMANN R
Citation: Fm. Rosenthal et al., CYTOKINE GENE-THERAPY WITH GENE TRANSFECTED CELLS - LONG-TERM EXPRESSION IN-VIVO AND THERAPEUTIC POTENTIAL, European journal of cancer, 31A, 1995, pp. 29-29
Authors:
MERTELSMANN R
LINDEMANN A
BOEHM T
BRENNSCHEIDT U
FRANKE B
KULMBURG P
LAHN M
MACKENSEN A
ROSENTHAL FM
VEELKEN H
Citation: R. Mertelsmann et al., PILOT-STUDY FOR THE EVALUATION OF T-CELL-MEDIATED TUMOR-IMMUNOTHERAPYBY CYTOKINE GENE-TRANSFER IN PATIENTS WITH MALIGNANT-TUMORS, Journal of molecular medicine, 73(4), 1995, pp. 205-206
Authors:
LINDEMANN A
ROSENTHAL FM
HASE S
MARKMEYER P
MERTELSMANN R
Citation: A. Lindemann et al., GUIDELINES FOR THE DESIGN AND IMPLEMENTATION OF CLINICAL-STUDIES IN SOMATIC-CELL THERAPY AND GENE-THERAPY, Journal of molecular medicine, 73(4), 1995, pp. 207-211
Authors:
VEELKEN H
KULMBURG P
ROSENTHAL FM
MACKENSEN A
MERTELSMANN R
LINDEMANN A
Citation: H. Veelken et al., NONVIRAL EX-VIVO TRANSFECTION OF PRIMARY HUMAN SKIN FIBROBLASTS FOR GENE-THERAPY, Journal of cellular biochemistry, 1995, pp. 386-386
Authors:
LINDEMANN A
ROSENTHAL FM
HASE S
MARKMEYER P
MERTELSMANN R
Citation: A. Lindemann et al., HINTS ON THE PLANNING AND IMPLEMENTATION OF CLINICAL-STUDIES IN THE AREA OF SOMATIC-CELL AND GENE-THERAPY, Medizinische Klinik, 90(2), 1995, pp. 103-106
Authors:
LINDEMANN A
ROSENTHAL FM
HASE S
MARKMEYER P
MERTELSMANN R
Citation: A. Lindemann et al., NOTES ON THE PLANNING AND IMPLEMENTATION OF CLINICAL-TRIALS IN THE FIELDS OF SOMATIC-CELL AND GENE-THERAPY, Onkologie, 18(1), 1995, pp. 85-89
Authors:
LINDEMANN A
VEELKEN H
MACKENSEN A
BRENNSCHEIDT U
KULMBURG P
ROSENTHAL FM
LAHN M
MERTELSMANN R
Citation: A. Lindemann et al., TUMORIMMUNOTHERAPY WITH INTERLEUKIN-2 GENE TRANSFECTED FIBROBLASTS - A PHASE-I STUDY, Experimental hematology, 23(8), 1995, pp. 852-852
Authors:
LINDEMANN A
ROSENTHAL FM
HASE S
MARKMEYER P
MERTELSMANN R
Citation: A. Lindemann et al., GUIDE FOR PLANNING AND IMPLEMENTING CLINI CAL-STUDIES IN THE AREAS OFSOMATIC-CELL AND GENE-THERAPY, Chirurg, 66(1), 1995, pp. 71-75
Authors:
MACKENSEN A
HERBST B
KOHLER G
WOLFFVORBECK G
ROSENTHAL FM
VEELKEN H
KULMBURG P
SCHAEFER HE
MERTELSMANN R
LINDEMANN A
Citation: A. Mackensen et al., DELINEATION OF THE DENDRITIC CELL LINEAGE BY GENERATING LARGE NUMBERSOF BIRBECK GRANULE-POSITIVE LANGERHANS CELLS FROM HUMAN PERIPHERAL-BLOOD PROGENITOR CELLS IN-VITRO, Blood, 86(7), 1995, pp. 2699-2707
Authors:
ROSENTHAL FM
SCHULTZE J
VEELKEN H
KULMBURG P
KOHLER G
CRONIN K
LINDEMANN A
MERTELSMANN R
GANSBACHER B
Citation: Fm. Rosenthal et al., EFFECTS OF AUTOCRINE AND PARACRINE SECRETION OF CYTOKINES ON INDUCTION OF ANTITUMOR IMMUNITY, Journal of cellular biochemistry, 1994, pp. 235-235
Authors:
VIEWEG J
ROSENTHAL FM
BANNERJI R
HESTON WDW
FAIR WR
GANSBACHER B
GILBOA E
Citation: J. Vieweg et al., IMMUNOTHERAPY OF PROSTATE-CANCER IN THE DUNNING RAT MODEL - USE OF CYTOKINE GENE MODIFIED TUMOR VACCINES, Cancer research, 54(7), 1994, pp. 1760-1765
Authors:
ALLIONE A
CONSALVO M
NANNI P
LOLLINI PL
CAVALLO F
GIOVARELLI M
FORNI M
GULINO A
COLOMBO MP
DELLABONA P
HOCK H
BLANKENSTEIN T
ROSENTHAL FM
GANSBACHER B
BOSCO MC
MUSSO T
GUSELLA L
FORNI G
Citation: A. Allione et al., IMMUNIZING AND CURATIVE POTENTIAL OF REPLICATING AND NONREPLICATING MURINE MAMMARY ADENOCARCINOMA CELLS ENGINEERED WITH INTERLEUKIN (IL)-2,IL-4, IL-6, IL-7, IL-10, TUMOR-NECROSIS-FACTOR-ALPHA, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, AND GAMMA-INTERFERON GENE OR ADMIXED WITH CONVENTIONAL ADJUVANTS, Cancer research, 54(23), 1994, pp. 6022-6026